Gluten Related Disorders in Barrett's Esophagus
Mechanisms Underlying Development of Barrett's Esophagus in Patients With Gluten Related Disorders
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
In a small group of people gluten, a storage protein commonly in wheat and other grains, can cause gut inflammation and symptoms like diarrhea and abdominal pain. Gluten-related disorders include celiac disease (CD) and non-celiac gluten sensitivity (NCGS) and are treated by starting a gluten free diet (GFD). Patients with CD and NCGS also more commonly experience esophageal reflux and damage to the lining of the esophagus. A potential consequence of long-standing heartburn is Barrett's esophagus (BE), a major risk factor for cancer of the esophagus. This study aims to investigate the mechanism that leads to reflux and BE in those with gluten related disorders, and to assess if a GFD is beneficial. We will study the upper gut function and reflux activity in patients with BE both with and without a GRD disorder. Testing will occur before and after a gluten free diet is instituted. The results will help inform health care providers and patients about the connection between gluten-related disorders, reflux, BE, and the role of GFD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedMarch 21, 2018
October 1, 2017
6 months
October 18, 2017
March 20, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Ratio of non-acidic to acidic reflux events
Proportion of non-acid to acid reflux events as determined by pH-impedance
At study start and at one month after a gluten free diet
Secondary Outcomes (5)
Reflux disease questionnaire
At study start and one month after a gluten free diet
Esophageal motility
At study start
Upper gastrointestinal motility
At study start
Leeds short form questionnaire
At study start and one month after a gluten free diet
Gastroesophageal reflux disease-health related quality of life instrument
At study start and one month after a gluten free diet
Study Arms (2)
Subjects with GRDs
EXPERIMENTALAn intervention of a change in diet, specifically a gluten free diet taught by a health care professional will be administered for one month's time.
Subjects without GRDs
ACTIVE COMPARATORAn intervention of a change in diet, specifically a gluten free diet taught by a health-care professional will be administered for one month's time.
Interventions
Eligibility Criteria
You may qualify if:
- Aged 18 years and over
- Barrett's Esophagus diagnosis based on endoscopy and esophageal biopsies
- Patients able to comply to the study procedures, according to the investigator's own judgment
You may not qualify if:
- Patients who have been on a gluten free diet within the last six months
- History of bariatric surgery, fundoplication, or gastrectomy (partial or complete)
- Connective tissue disease
- Concurrent organic GI pathology other than benign polyps, haemorrhoids, lipomas, H. pylori infection, diverticulosis, and melanosis coli
- Chronic treatment with high dose opioids
- Alcohol or drug abuse
- Pregnant or breastfeeding women. Women enrolling in the study will be advised to avoid pregnancy during the course of the study by using adequate birth control such as abstinence, oral contraceptive pill, barrier contraceptives (i.e condom). If a subject becomes pregnant she will be withdrawn from the study.
- Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be a risk or that could interfere with data collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Premysl Bercik, MD
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2017
First Posted
November 6, 2017
Study Start
April 1, 2018
Primary Completion
September 30, 2018
Study Completion
December 30, 2018
Last Updated
March 21, 2018
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share